Eton Pharmaceuticals, Inc. announced that it has appointed Paul Stickler as the company’s new Senior Vice President of Sales and Marketing. Stickler brings more than twenty-five years of pharmaceutical sales and marketing experience with a primary focus in orphan and neurology products. In the new role, he will be responsible for the expected launch of Eton’s orphan product Alkindi Sprinkle in the fourth quarter of 2020, as well as the future commercialization of Eton’s pediatric neurology pipeline products. Prior to joining Eton Pharmaceuticals, Stickler was Vice President of Commercial Operations at Recordati Rare Diseases, a billion-dollar global pharmaceutical company focused on orphan and rare disease products.